Balance Sheet for Fortress Biotech Inc. (FBIO)

$ 2.62   -0.09 (-3.32%) Volume: 635.7k 4:00 PM EDT Jul 13, 2020
After Hours:  $ 2.59   -0.03 (-1.15%) Volume: 11.02k 7:24 PM EDT Jul 13, 2020
Statement: View:
Assets [+] in Thousands of Dollars
12/2019 12/2018 12/2017 12/2016 12/2015
Cash and Equivalents 136,858 65,508 94,952 88,294 98,182
Restrictable Cash 14,929 - - - -
Marketable Securities - 17,604 36,002 3,387 -
Accounts Receivable 13,539 5,498 7,758 1,830 -
Loans Receivable - 4,742 1,616 1,712 -
Other Receivables - 31,760 7,395 3,357 -
Receivables 14,404 7,593 8,376 8,689 156
Inventories, Raw Materials - - - - -
Inventories, Work in Progress - - - - -
Inventories, Purchased Components - - - - -
Inventories, Finished Goods - - - - -
Inventories, Other 857 678 171 203 -
Inventories, Adjustments & Allowances - - - - -
Inventories 857 678 171 203 -
Prepaid Expenses 4,133 6,735 5,732 9,061 1,599
Current Deferred Income Taxes - - - - -
Other Current Assets - - - 1,030 -
Total Current Assets 156,252 111,207 183,181 109,634 99,937
Land and Improvements - - - - -
Buildings and Improvement 9,358 9,271 5,351 5,655 21
Machinery, Furniture and Equipment 6,404 4,919 1,695 1,926 82
Construction in Progress 1,157 393 1,241 - 274
Fixed Assets, Other 21,480 - - 276 -
Fixed Assets, Total 38,399 14,583 8,287 7,857 377
Gross Fixed Assets 38,399 14,583 8,287 7,857 377
Accumulated Depreciation (4,486) (2,564) (1,171) (481) (68)
Net Fixed Assets 33,913 12,019 7,116 7,376 309
Intangibles 7,377 1,417 883 17,408 1,250
Cost in Excess - 55,935 18,645 18,645 -
Non-Current Deferred Income Taxes - - - - -
Other Non-Current Assets 17,732 16,350 53,380 16,254 14,629
Total Non-Current Assets 70,170 29,786 62,769 61,097 18,673
Total Assets 226,422 140,993 245,950 170,731 118,610
Liabilities [+] in Thousands of Dollars
12/2019 12/2018 12/2017 12/2016 12/2015
Accounts Payable 35,451 34,216 27,634 24,295 10,438
Short Term Debt 9,004 19,078 13,228 1,031 -
Notes Payable - - - 1,000 -
Accrued Expenses 1,134 1,329 984 12,105 27
Accrued Liabilities 1,134 1,329 984 12,105 27
Deferred Revenues - 1,495 680 - -
Current Deferred Income Taxes - - - (73) -
Other Current Liabilities 27 (504) 28,912 18,134 114
Total Current Liabilities 45,616 55,614 71,438 56,565 10,579
Long Term Debt 82,426 60,425 49,271 26,184 23,174
Deferred Income Tax 2,136 5,211 4,739 5,014 493
Other Non-Current Liabilities 2,135 5,210 4,738 5,014 584
Minority Interest 46,317 17,891 67,929 44,473 27,427
Capital Lease Obligations 23,712 - - - -
Preferred Securities of Subsidiary Trust - - - - -
Preferred Equity Outside Shareholders' Equity - - - - -
Total Non-Current Liabilities 154,591 83,527 121,939 75,671 51,185
Total Liabilities 200,207 139,141 193,377 132,236 61,764
Preferred Shareholder's Equity 1 1 1 - -
Common Shareholder's Equity 26,214 1,851 52,572 38,495 56,846
Common Par 574 717 551 49 47
Additional Paid in Capital 461,874 397,408 364,148 283,697 246,955
Cumulative Translation Adjustments - - - - -
Retained Earnings (436,234) (396,274) (312,127) (245,251) (190,156)
Treasury Stock - - - - -
Other Equity Adjustments - - - - -
Total Capitalization 108,641 62,277 101,844 64,679 80,020
Total Equity 26,215 1,852 52,573 38,495 56,846
Total Liabilities & Shareholder's Equity 226,422 140,993 245,950 170,731 118,610
Cash Flow (101,660) (141,936) (99,836) (74,046) (54,223)
Working Capital 110,636 55,593 111,743 53,069 89,358
Free Cash Flow (104,356) (108,204) (85,318) (56,318) (32,359)
Invested Capital 108,641 62,277 101,844 64,679 80,020
Shares Outstanding - Common Class Only 74,027 57,845 50,991 48,932 47,147
Preferred Shares Outstanding 1,341 1,000 1,000 - -
Total Ordinary Shares 74,027 57,845 50,991 48,932 47,147
Total Common Shares Outstanding 74,027 57,845 50,991 48,932 47,147
Treasury Shares - - - - -
Basic Weighted Shares Outstanding 54,712 43,462 41,659 39,963 39,147
Diluted Weighted Shares Outstanding 54,712 43,462 41,659 39,963 39,147